Marcelline Kemmy

Marcelline Kemmy

Auto-generated profile, based on publicly available information

Marcelline Kemmy

Department of Orthopaedic Surgery, University of Illinois Chicago, Chicago, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2026 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
ARAli Rteil
Ali Rteil
MMMajd Mzeihem
Majd Mzeihem
MKMarcelline Kemmy
Marcelline Kemmy
HPHristo Piponov
Hristo Piponov
LPLalit Puri
Lalit Puri
FAFarid Amirouche
Farid Amirouche
Background: Patients with spinopelvic risk factors such as lumbar fusion or stiff spine exhibit a 5- to 10-fold increased risk of dislocation following total hip arthroplasty (THA), primarily due to altered spinopelvic mechanics that influence cup positioning. The utilization of robotic-assisted THA facilitates personalized planning, enhancing component placement in this high-risk population. This study aims to compare rates of implant-related and medical complications between robotic-assisted and manual THA in these high-risk patients. Methods: Data were retrospectively obtained from the TriNetX Research Network. Patients with prior lumbar fusion or spinal conditions associated with stiffness or malalignment, and who subsequently underwent THA, were identified using ICD-10 and CPT codes. Procedure codes defined robotic-assisted and manual THA. After 1:1 propensity score matching for age, sex, body mass index, smoking status, and other comorbidities, outcomes were compared at 3, 6, 12 months and 2 years. A subgroup analysis compared both groups in spinal fusion (SF) and nonfusion (no-SF/stiff spine) patients. Results: After 1:1 propensity score matching, each cohort included 2,147 patients. At 3 months, robotic THA was associated with lower prosthetic complications (1.4 vs 2.7%; odds ratio [OR]: 1.86, 95%; P = 0.01) and postoperative blood transfusion (0.9 vs. 1.8%; OR: 2.02, P = 0.01). At 1 year, dislocation was reduced (0.9 vs. 1.8%; OR: 2.07; P = 0.01). Revisions were also lower at 1 and 2-year follow-up in the robotic group (1.7 vs. 2.7%, OR: 1.61; 2.0 vs 3.7%, OR: 1.86; all P < 0.05; respectively), and the manual group had 1.9 times the hazard of having revision surgery at 2 years (HR: 1.9, 95%; P = 0.02). In no-SF patients, robotic THA was associated with markedly lower rates of prosthetic complications and revision surgery. Conclusion: Robotic-assisted THA was associated with fewer complications than manual THA in patients with lumbar fusion or clinically relevant spinal stiffness, a population at elevated risk for instability after THA. Precision-based implant positioning may improve outcomes in patients with altered spinopelvic mobility, including those without spinal fusion.

20 August 2026 in International Orthopaedics
Verified
Journal Article
Open access
PDF file
PCPeter Chebi
Peter Chebi
ACApurva Choubey
Apurva Choubey
RRRyan Rutherford
Ryan Rutherford
JMJoseph Michalski
Joseph Michalski
MKMarcelline Kemmy
Marcelline Kemmy
BGBenjamin Goldberg
Benjamin Goldberg
Purpose: The increasing prevalence of Glucagon-like peptide-1 receptor agonists (GLP-1 RA) has raised concerns about their perioperative impact. Although database studies on GLP-1 RAs in total shoulder arthroplasty (TSA) have been published for diabetic and general TSA patients, results are conflicting, and the effects on patients across various obesity classes remain unexplored. This study aims to fill this gap. Methods: The PearlDiver database was used to identify patients who underwent primary TSA, grouped by GLP-1 use, obesity status, and obesity class. Post-operative outcomes included 90-day readmission and emergency department (ED) visit rates, medical complications (including thromboembolic, infectious, and renal events), and orthopaedic complications (including revision, periprosthetic joint infection, and instability). Cohorts were matched 10:1 by exact matching on age, sex, Elixhauser comorbidity index, diabetes, hypertension and overall obesity status, and multivariable regression was used to adjust for comorbidities that remained imbalanced after matching. Results: Among 95,566 patients, 1,549 (1.62%) were GLP-1 users. Initially, GLP-1 users exhibited higher pre-operative comorbidity burdens and rates of complications. However, after matching and multivariable adjustment for residual imbalance, no significant differences in medical or orthopaedic outcomes persisted. Notably, GLP-1 users demonstrated significantly lower odds of 90-day ED visits (OR 0.75; P < .01) and readmissions (OR 0.71; P < .01). Similar trends were observed within each individual obesity class, but none reached statistical significance, most likely reflecting the small size of these subgroups. Conclusion: After accounting for pre-operative comorbidities, our findings suggest that GLP-1 RA use is not associated with worse surgical outcomes in TSA patients and may be associated with lower post-operative healthcare utilisation, although residual confounding cannot be excluded. Further longitudinal studies are warranted to optimise perioperative GLP-1 RA administration.